Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of multiple doses of intramuscular versus intranasal naloxone for reversal of opioid toxicity
2023-505338-93-00Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of naloxone in opioid intoxication and hypopnea (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Number of naloxone administrations. Started Aug 2023; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxicationhypopnea
Beyond the preview
Go deeper on 2023-505338-93-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505338-93-00.